TY - JOUR
T1 - Interventions for age-related diseases
T2 - Shifting the paradigm
AU - Figueira, Inês
AU - Fernandes, Adelaide
AU - Mladenovic Djordjevic, Aleksandra
AU - Lopez-Contreras, Andres
AU - Henriques, Catarina M
AU - Selman, Colin
AU - Ferreiro, Elisabete
AU - Gonos, Efstathios S
AU - Trejo, José Luis
AU - Misra, Juhi
AU - Rasmussen, Lene Juel
AU - Xapelli, Sara
AU - Ellam, Timothy
AU - Bellantuono, Ilaria
N1 - Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Over 60% of people aged over 65 are affected by multiple morbidities, which are more difficult to treat, generate increased healthcare costs and lead to poor quality of life compared to individual diseases. With the number of older people steadily increasing this presents a societal challenge. Age is the major risk factor for age-related diseases and recent research developments have led to the proposal that pharmacological interventions targeting common mechanisms of ageing may be able to delay the onset of multimorbidity. Here we review the state of the knowledge of multimorbidity, appraise the available evidence supporting the role of mechanisms of ageing in the development of the most common age-related diseases and assess potential molecules that may successfully target those key mechanisms.
AB - Over 60% of people aged over 65 are affected by multiple morbidities, which are more difficult to treat, generate increased healthcare costs and lead to poor quality of life compared to individual diseases. With the number of older people steadily increasing this presents a societal challenge. Age is the major risk factor for age-related diseases and recent research developments have led to the proposal that pharmacological interventions targeting common mechanisms of ageing may be able to delay the onset of multimorbidity. Here we review the state of the knowledge of multimorbidity, appraise the available evidence supporting the role of mechanisms of ageing in the development of the most common age-related diseases and assess potential molecules that may successfully target those key mechanisms.
U2 - 10.1016/j.mad.2016.09.009
DO - 10.1016/j.mad.2016.09.009
M3 - Review
C2 - 27693441
SN - 0047-6374
VL - 160
SP - 69
EP - 92
JO - Mechanisms of Ageing and Development
JF - Mechanisms of Ageing and Development
ER -